Latest news
07.20.2020
Here’s how being denied for a credit card impacts your credit score
Being denied for a credit card doesn’t hurt your credit score. But the hard inquiry from submitting an application can cause your score to decrease.
What New Parents Should Know About Life Insurance
Having a baby can bring the gaps in your financial plan into sharp focus. New parents often feel they need to find ways to provide financial security...
Why Searching for Cheap Stocks Is the Wrong Investing Strategy
The premise makes more than enough sense: For the same reason consumers want more bang for their buck at the stores they regularly shop...
Private credit lenders seek protection in minimum liquidity protocol
Private credit firms are requiring their borrowers maintain a strong liquidity cushion as the coronavirus pandemic forces middle market companies...
Consumer credit fell at a slower 5.3% in May as the economy began to recover
The use of credit cards fell at a much slower pace in May as the economy began to recover and the government provided financial relief to households...
Latest news
07.20.2020
Stocks making
the biggest moves
premarket:
Nikola, Apple, Biogen,
Intersect ENT & more
ByFred Imbert, Markets Reporter
Check out the companies making headlines before the bell:
Intersect ENT (XENT), Medtronic (MDT) — Shares of Intersect ENT popped 35% after Bloomberg News reported Medtronic has made an offer to acquire the California-based medical device company. Though talks are still in their early stages, Intersect’s board is reviewing the offer, according to the report.
National General (NGHC), Allstate (ALL) — National General shares surged more than 67% on news the company would be acquired by insurance giant Allstate. The deal, which is expected to close early next year, is worth $4 billion, or $34.50 per share, in cash. Allstate shares fell 2.5%.
Nikola (NKLA) — An analyst at JPMorgan upgraded the electric truck maker to “overweight” from “neutral,” noting the stock is “starting to look attractive for long-term investors in view of a number of potential positive catalysts in coming weeks and months.” Nikola shares rose more than 7% in the premarket.
Apple (AAPL) — Deutsche Bank hiked its price target on Apple to $400 per share from $380 per share, implying a 7.3% upside from Tuesday’s close of $372.69. “Overall, we feel comfortable that AAPL should continue to offer upside for investors,” a Deutsche Bank analyst said in a note. However, the analyst noted the stock’s recently sharp run-up “has us nervous.”
Biogen (BIIB) — Biogen shares jumped nearly 7% after the company submitted an application to the Food and Drug Administration for aducanumab as a treatment for Alzheimer’s disease. “If approved, aducanumab would be the first treatment with the potential to meaningfully change the course of Alzheimer’s disease,” Biogen said in a release.
Altria (MO) — Shares of the tobacco giant were downgraded to “equal weight” from “overweight” by a Barclays analyst. The analyst noted Altria is “100% U.S.-exposed and continues to lose market share.”
Caterpillar (CAT) — A Bank of America analyst upgraded the construction giant to “neutral” from “underperform,” and hiked its price target on the stock to $135 per share. “We still have our doubts on the sustainability of macro improvement, but are tempering our negativity,” the analyst said. Caterpillar climbed 1.1% before the bell.
American Express (AXP) — American Express was downgraded to “neutral” from “buy” by an analyst at Citigroup, citing the potential for “top line headwinds” moving forward. The analyst also trimmed his price target on the company to $105 per share from $110 per share. American Express shares slid 0.6% in the premarket.
This article was originally published By Fred Imbert, cnbc.com.
VantageScore 3.0: What's a Great
Credit Score?
Why an Excellent
Credit Score
Matters
MONEY • BEST • CREDIT CARDS • SCORE
We updated our privacy policy as of June 03, 2020. Learn about our personal information collection practices here.